Serum prolactin in patients with relapsing remitting multiple sclerosis

Table 1 Comparison of serum PRL and TNFα among the studied groups

	MS patients in relapse	MS patients in remission	Control subjects	P value
Median serum PRL (ng/ml)	12.5 (5.4–39.9)^a	9.6 (4.3–23.9)	11.45 (4.1–24.0)	0.041*
Serum TNFα (mean + SD) (pg/ml)	59.77 + 21.27^ab (28.6-102.7)	48.79 + 14.55 (29.1–88.1)	37.87 + 14.02 (21.6–62.3)	0.001*

^aSignificant P value (MS patients in relapse vs MS patients in remission)
^bSignificant P value (MS patients in relapse vs control subjects MS multiple sclerosis, PRL prolactin, TNFα tumor necrosis factor alpha)